Data-Driven Disease Insight We collaborate with our customers to unravel the complexities of human disease biology, reducing the risk and cost of therapy development. We generate data driven disease insights through a unique combination of AI driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers our customers to draw their own conclusions and take a data driven approach to disease and drug research. Euretos AI Platform The Euretos AI Platform empowers researchers to draw evidence-based conclusions. It is used indepently but also as an integral part of our consulting projects. Leverage information from millions of machine-read publications and hundreds of data sources such as genetic, genomic and proteomic annotations, expression profiles, patents and much more. Generate hypotheses and evaluate evidence using a suite of applications including Search, Analytics, Knowledge Graph and many task-optimised Workflows. Target Discovery / Indication Selection Consulting In our projects we focus on target discovery and indication selection. In these areas, our computational disease models and translational biology consulting have been tried and tested in many collaborations with leading pharma and biotech companies. Our translational consultants will help you interpret the outcomes of our computational disease modeling. In addition, direct access to the Euretos AI Platform enables you to review results within the context of existing evidence from public biomolecular databases, publications and patents. Combine your proprietary data and therapeutic expertise with our disease models, translational consultants and AI platform to gain collaborative, data driven disease insights.